SEARCH

SEARCH BY CITATION

References

  • 1
    Balakrishnan A,Bleeker FE,Lamba S,Rodolfo M,Daniotti M,Scarpa A,van Tilborg AA,Leenstra S,Zanon C,Bardelli A. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res 2007; 67: 354550.
  • 2
    Sequist LV,Bell DW,Lynch TJ,Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol 2007; 25: 58795.
  • 3
    Herranz M,Esteller M. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol 2007; 361: 2562.
  • 4
    Friedberg EC,Henning K,Lambert C,Saxon PJ,Schultz RA,Sekhon GS,Stanbridge EJ. Microcell-mediated chromosome transfer: a strategy for studying the genetics and molecular pathology of human hereditary diseases with abnormal responses to DNA damage. Basic Life Sci 1990; 52: 25767.
  • 5
    Modrich P,Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 1996; 65: 10133.
  • 6
    Papadopoulos N,Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997; 10: 8999.
  • 7
    Bronner CE,Baker SM,Morrison PT,Warren G,Smith LG,Lescoe MK,Kane M,Earabino C,Lipford J,Lindblom A,Tannergard P,Bollag RJ, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258261.
  • 8
    Landis SH,Murray T,Bolden S,Wingo PA. Cancer statistics, 1999. Cancer J Clin 1999; 49: 8.
  • 9
    Bokemeyer C,Kollmannsberger C,Hartmann JT,Kanz L. Follow-up after primary treatment: curable diseases treated non-surgically. Ann Oncol 2000; 11 ( Suppl 3): 738.
  • 10
    Rabbani F,Sheinfeld J,Farivar-Mohseni H,Leon A,Rentzepis MJ,Reuter VE,Herr HW,McCaffrey JA,Motzer RJ,Bajorin DF,Bosl GJ. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 2001; 19: 20205.
  • 11
    Eggener SE,Carver BS,Loeb S,Kondagunta GV,Bosl GJ,Sheinfeld J. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer 2007; 109: 52835.
  • 12
    Leach FS,Velasco A,Hsieh J-T,Sagalowsky AI,McConnell JD. The human mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP. J Urol 2000; 164: 183033.
  • 13
    Velasco A,Hewitt S,Saboorian H,Rosenberg H,Martinez C,Sagalowsky AI,McConnell JD,Linehan M,Leach FS. Differential expression of the mismatch repair gene hMSH2 in benign and malignant prostate tissue. Cancer 2002; 94: 6909.
  • 14
    Velasco A,Alberts PS,Rosenberg H,Martinez C,Leach FS. Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer. Cancer Biol Ther 2002; 1: 362367.
  • 15
    Devouassoux-Shisheboran M,Maudit C,Bouvier R,Berger F,Bouras M,Droz JP,Berahmed M. Expression of hMLH1 and hMSH2 and MSI in testicular and mediastinal germ cell tumours. Mol Hum Reprod 2001; 7: 10991105.
  • 16
    Watanabe M,Shiraishi T,Muneyuki T,Nagai M,Fukutom K,Murata M,Kawamura J,Yatani R. Allelic loss and microsatellite instability in prostate cancers in Japan. Oncology 1998; 55: 56974.
  • 17
    Olasz J,Mandoky L,Geczi L,Bodrogi I,Csuka O,Bak M. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Anticancer Res 2005; 25: 431924.
  • 18
    Egawa S,Uchida T,Suyama K,Wang C,Ohori M,Irie S,Iwamura M,Koshiba K. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 1995; 55: 241821.
  • 19
    Uchida T,Wada C,Wang C,Ishida H,Egawa S,Yokoyama E,Ohtani H,Koshiba K. Microsatellite instability in prostate cancer. Oncogene 1995; 10: 101922.
  • 20
    Velasco A,Riquelme E,Schultz M,Wistuba II,Villarroel L,Koh MS,Leach FS. Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence. Cancer Biol Ther 2004; 3: 11528.
  • 21
    Velasco A,Riquelme E,Schultz M,Wistuba II,Villarroel L,Pizarro J,Berlin A,Ittmann M,Koh MS,Leach FS. Mismatch repair gene expression and genetic instability in testicular germ cell tumor. Cancer Biol Ther 2004; 3: 97782.